Conversely, models such as SCN1A mutant mice (Dravet syndrome) demonstrate limited or variable responses to GABA-T inhibition because their underlying pathology reflects sodium channel dysfunction rather than primary deficits in GABAergic inhibition [119]. This evidence concerns the gene SCN1A and Dravet syndrome.